Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of DSG 1% compared with placebo applied four times a day in subjects with acute blunt soft tissue injuries/contusions of the limbs


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01272947
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date January 2011
Completion date July 2011

See also
  Status Clinical Trial Phase
Completed NCT02290821 - Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries Phase 3